Skip to main content
UCB SA (UCBJY)
OTCMKTS · Delayed Price · Currency is USD
144.05
+4.65 (3.33%)
Dec 5, 2025, 1:10 PM EST

UCB SA Revenue

UCB SA had revenue of 3.49B EUR in the half year ending June 30, 2025, with 38.43% growth. This brings the company's revenue in the last twelve months to 6.85B, up 25.56% year-over-year. In the year 2024, UCB SA had annual revenue of 6.15B with 18.72% growth.

Revenue (ttm)
6.85B EUR
Revenue Growth
+25.56%
P/S Ratio
6.80
Revenue / Employee
730.22K EUR
Employees
9,378
Market Cap
54.70B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20246.15B970.00M18.72%
Dec 31, 20235.18B-265.00M-4.87%
Dec 31, 20225.45B-330.00M-5.71%
Dec 31, 20215.78B430.00M8.04%
Dec 31, 20205.35B434.00M8.83%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Veradigm 588.02M
Elite Pharmaceuticals 122.89M
Glass House Brands 196.17M
American Oncology Network 1.76B
Northwest Biotherapeutics 937.00K
Silence Therapeutics 25.83M
Global Cord Blood 196.10M
Zomedica 29.45M
Revenue Rankings

UCB SA News

More News